Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$15.55
+4.54%
Mkt Cap $398.96M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$33.00
Range $29.00 – $35.00
Implied Upside
+112.3%
Consensus $33.00 vs current $15.55
NASDAQ·Healthcare·Biotechnology
$15.55
+4.54%
Mkt Cap $398.96M
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$33.00
Range $29.00 – $35.00
+112.3%
Consensus $33.00 vs current $15.55